15.15:

The Unfolded Protein Response

JoVE Core
Cell Biology
Bu içeriği görüntülemek için JoVE aboneliği gereklidir.  Oturum açın veya ücretsiz deneme sürümünü başlatın.
JoVE Core Cell Biology
The Unfolded Protein Response

3,647 Views

01:37 min

April 30, 2023

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding pathways in the cell.

UPR detectors for misfolded proteins

Each of the three UPR receptors, IRE1, PERK, and ATF6, sense misfolded proteins and manage cell processes that allow clearance of misfolded proteins from the ER. Active IRE1 is responsible for upregulating the synthesis of ERAD machinery to accelerate the export of misfolded proteins, whereas active PERK stalls ribosomes during protein synthesis. Thus, these two signaling arms manage to balance the clearance and synthesis of proteins to alleviate ER stress. At the same time, the N-terminal region of ATF6 acts as a transcription factor to signal the upregulation of ER chaperones, such as BiP, lectins, and protein disulfide isomerase. These proteins aid in either refolding of misfolded proteins or their transport back to the cytosol for degradation.

UPR and ERAD for protein homeostasis

Under normal conditions, the ERAD is active at low levels. However, when the concentration of misfolded proteins increases in the ER, the number of chaperone molecules and components of retrotranslocation machinery is insufficient to clear this protein pile up, resulting in proteotoxic stress. UPR upscales the clearance of misfolded proteins via ERAD or lysosomal degradation. If the UPR cannot restore cellular homeostasis, the cell uses JNK protein kinase and caspases to trigger apoptotic programs.